Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY60.17 CNY
Change Today 0.00 / 0.00%
Volume 0.0
600211 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 05/21/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by TIBET RHODIOLA PHARM-A (600211) in the last 6 months

Announced 07/29/15
41.00M for Sichuan Bencaotang Pharmaceutical Co.,Ltd.
Merger/Acquisition

Huang Dingzhong agreed to acquire an additional 51% stake in Sichuan Bencaotang Pharmaceutical Co., Ltd from Tibet Rhodiola Pharmaceutical Holding Company (SHSE:600211) for CNY 41.3 million in cash on July 28, 2015. The transaction was unanimously approved by Board of Tibet Rhodiola Pharmaceutical Holding on July 28, 2015. Sichuan Bencaotang Pharmaceutical Co.,Ltd. reported total assets of CNY 372.3 million, total owner’s equity of CNY 25.5 million, revenue of CNY 1.2 ...
Read More


600211's price was unchanged after the transaction was announced on 07/29/15.
Creditor / Lender
Tibet Rhodiola Pharmaceutical Holding Company
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600211:CH CNY60.17 CNY 0.00

600211 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600211.
View Industry Companies
 

Industry Analysis

600211

Industry Average

Valuation 600211 Industry Range
Price/Earnings 100.0x
Price/Sales 5.0x
Price/Book 21.2x
Price/Cash Flow 413.5x
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIBET RHODIOLA PHARM-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.